Contact
Please use this form to send email to PR contact of this press release:
Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma
TO:
Please use this form to send email to PR contact of this press release:
Cobomarsen Receives Orphan Drug Designation From the U.S. FDA for the Treatment of T-cell Lymphoma
TO: